Tempest Therapeutics Inc. Gains 85.16%
Mon, Oct 16, 2023 at 07:18 PM
Tempest Therapeutics Inc. (TPST:NASDAQ) jumped higher at $6.74, a gain of 85.2%. The stock appeared on our News Catalysts scanner on Wed, Oct 11, 2023 at 12:01 PM in the 'BIOTECH' category. From Mon, Oct 02, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Oct 11, 2023 at $9.77 with a volume of 173M+.
About Tempest Therapeutics Inc. (TPST:NASDAQ)
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific...
Top 10 Gainers:
- Tempest Therapeutics Inc. (TPST:NASDAQ), 85.16%
- Mmtec, Inc. (MTC:NASDAQ), 64.43%
- Secoo Holding Limited (SECO:NASDAQ), 59.47%
- Momentus Inc. (MNTS:NASDAQ), 55.95%
- PCTEL, Inc. (PCTI:NASDAQ), 47.21%
- Dunxin Financial Holdings Limited (DXF:NYSEMKT), 45.28%
- MingZhu Logistics Holdings Limited (YGMZ:NASDAQ), 38.36%
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 34.53%
- Almacenes Exito S.A. American Depositary Share each representing eight (8) (EXTO:NYSE), 34.46%
- a.k.a. Brands Holding Corp. (AKA:NYSE), 34.23%